Research Article

Proportions of Proinflammatory Monocytes Are Important Predictors of Mortality Risk in Hemodialysis Patients

Table 4

The multiple Cox regression analysis results for death risk.

Outcome typesCVD deathAll-cause death
CovariatesHR95% CI valueHR95% CI value

CD16+ monocytes, %
 Q4 versus Q312.813.7244.09<0.0013.261.497.140.003
 Q4 versus Q230.857.12133.8<0.0015.282.0713.49<0.001
 Q3 versus Q22.410.5810.030.2271.620.614.290.333
Follow-up time ≤ 3.5 years
 Q1 versus Q21.630.1517.330.6850.90.263.160.875
 Q4 versus Q118.922.17164.90.0085.841.7119.980.005
 Q3 versus Q11.480.1613.470.731.790.526.170.358
Follow-up time > 3.5 years
 Q1 versus Q210.92.4248.960.0024.381.4513.240.009
 Q4 versus Q12.830.819.860.1021.210.443.290.716
 Q3 versus Q10.220.050.910.0370.370.131.070.067
Baseline medical condition
 CeVD history, yes versus no6.982.1822.30.0012.741.415.320.003
 CAD history, yes versus no44.5713.1151.7<0.0019.44.5319.48<0.001
 CAD history versus CeVD history6.391.7922.80.0043.431.348.750.01
Age, >q2 versus others2.881.147.280.0252.361.244.520.009
Cholesterol, >q2 versus others2.981.197.440.02
Platelet, >q2 versus others7.232.6619.67<0.0013.992.047.79<0.001
Cr
 ≤q1 versus others4.261.8210<0.001
 ≤q2 versus others4.492.318.75<0.001
UA, ≤q1 or >q3 versus others7.382.4722.01<0.0012.51.354.620.003
SBP, >q2 versus others5.111.9213.590.001
DBP, ≤q1 or >q3 versus others7.432.6221.06<0.0014.081.988.4<0.001
rTG, >q3 versus others0.180.070.47<0.0010.210.090.47<0.001
Ferritin, >q3 versus others0.450.230.870.018

Note: the abbreviations are the same as those indicated in Table 1. q1, q2, and q3 denoted the three quartiles—the first quartile, median, and the third quartile—of each covariate and the values were listed in Table 1. Q1, Q2, Q3, and Q4 here denoted the four ascending categories derived from the categorized CD16+ monocyte levels by its three quartiles. indicates values of less than 0.05.